Key Stats for Credo Stock
- Current Price: $265.55
- Target Price (Mid): ~$705
- Street Target: ~$270
- Potential Total Return: ~166% (over ~4.8 years)
- Annualized IRR: ~23% / year
- Earnings Reaction: +1.28% (June 1, 2026)
- Max Drawdown: 53.59% (March 30, 2026)
Now Live: Discover how much upside your favorite stocks could have using TIKR’s new Valuation Model (It’s free) >>>
What Happened?
Credo Technology Group (CRDO) closed up 9.77% on Monday at $265.55, extending a momentum run that has carried the stock through most of the summer. The fuel is a wall of bullish research: through late June, Wall Street raised its targets in a cluster, with the newest numbers landing between $325 and $350, well above where the stock trades. Yet there is a second signal that complicates the picture. Through June, every Credo insider who traded was a seller. The CEO, the CFO, the CTO, the chief legal officer, and a director all filed sales worth a combined $76.9 million, and none of them bought a single share in the open market.
The timing is the nuance that matters. Those insider sales happened in June, at prices between roughly $206 and $250, before this week’s push to $265. So this is not leadership dumping into Monday’s pop. It is leadership having trimmed steadily on the way up, even as analysts kept raising their targets. The question the market has to weigh is which signal to trust: a Street calling for $350, or the people who run the company quietly taking chips off the table a few weeks and 20% ago.
Why Wall Street Turned Aggressive on Credo Stock
The bullish case rests on results that are hard to argue with. Credo reported fiscal 2026 revenue of $1.335 billion, up 206% year over year, with fourth-quarter revenue of $437.0 million alone exceeding the company’s entire fiscal 2025 sales. Non-GAAP diluted earnings came in at $1.16 per share for the quarter, beating the $1.03 consensus. The stock’s reaction to that June 1 print was oddly muted, up just 1.28%, because the run into earnings had been so sharp.
The target hikes came later and hit in a cluster. Evercore ISI initiated coverage on June 22 with an Outperform rating and a $325 target. The same day, Stifel lifted its target to $350 after multi-day meetings with management. BofA followed on June 23, raising its number to $340 and tying the call to a stronger semiconductor demand outlook through 2030. For a stock whose Street mean target sat near $270, three fresh numbers north of $325 gave momentum buyers a reason to keep pressing.
The reason analysts are paying up is a second business layering on top of the first. Credo built its name on active electrical cables (AECs), short copper cables with built-in signal processors that link GPUs to switches inside AI racks. At the Bank of America 2026 Global Technology Conference on June 4, CEO Bill Brennan pushed back hard on the idea that copper is a dead end. “It’s going to be a heterogeneous world,” he argued, meaning copper and optical solutions each win different parts of the network rather than one replacing the other. That reframing matters because it turns a perceived ceiling into a runway.
Brennan went further on the optical opportunity. He said three optical product lines, optical DSPs, silicon photonics chips, and ZeroFlap Optics, will each grow past $100 million and together clear more than $600 million in fiscal 2027. Credo closed its roughly $750 million acquisition of DustPhotonics on May 28, bringing silicon photonics (chips that move data using light) in-house. CFO Dan Fleming framed the financial payoff plainly: fiscal 2027 revenue should grow more than 80% while operating expenses grow around 50%, because as he put it, “there’s continuing leverage in the model.” A second engine scaling faster than the company, with costs lagging revenue, is the kind of setup that earns a growth multiple.
See historical and forward estimates for Credo stock (It’s free!) >>>
The Signal Cutting the Other Way
Here is what the target hikes leave out. While analysts were raising numbers through June, Credo’s own leadership was selling. CEO Bill Brennan sold 54,984 shares on June 5 for about $12 million. CFO Dan Fleming sold 40,000 shares on June 11 for roughly $10 million. The CTO, the chief legal officer, and a director added more. In total, insiders sold $76.9 million in stock last quarter, and there were no open-market purchases. Insiders still own about 11.84% of the company, so this is trimming, not an exit.
Context matters before anyone reads too much into it. These sales ran through Rule 10b5-1 plans, pre-arranged programs that schedule trades in advance to avoid the appearance of acting on inside information, and the leadership team received large equity awards in May that keep them heavily aligned. So the selling is not a red flag by itself, and executives at fast-appreciating stocks sell on these plans routinely. What it does do is temper the idea that the people closest to the business see the same one-way upside the $350 targets imply. When insiders trim steadily into a rally, and analysts chase it, the reasonable reading is that the easy money has likely already been made.
That tension shows up directly in the valuation. Credo trades at an NTM EV/EBITDA of around 37x, against a semiconductor peer mean near 32x. On forward revenue, Credo sits near 20x versus a peer average close to 11x. Marvell, its closest connectivity rival, trades near 44x forward EBITDA, while NVIDIA sits near 16x. Is the premium justified? On growth, the case holds: Credo’s forward two-year revenue CAGR of around 65% is faster than any large-cap peer in the group, and a company tripling revenue while holding 68% gross margins earns a multiple. The risk is that a stock priced this richly has almost no cushion. Any deceleration, even from extraordinary to merely strong, compresses the multiple hard, and the beta on this name runs above 3.
See how Credo performs against its peers in TIKR (It’s free!) >>>
TIKR Advanced Model Analysis
- Current Price: $265.55
- Target Price (Mid): ~$705
- Potential Total Return: ~166%
- Annualized IRR: ~23% / year
See analysts’ growth forecasts and price targets for Credo stock (It’s free!) >>>
Using TIKR’s mid-case scenario, realized at fiscal year-end April 30, 2031, the model points to a target of around $705, a total return of around 166% over roughly 4.8 years, and an annualized IRR of around 23% per year. That number sits far above the Street’s ~$270 mean, so treat it as a long-horizon model output rather than a 12-month call.
The target rests on two revenue CAGR drivers: continued AEC adoption as Neo cloud operators broaden the customer base, and the optical ramp of ZeroFlap Optics, silicon photonics, and optical DSPs toward the $600 million-plus fiscal 2027 goal. The margin driver is operating leverage, with management targeting non-GAAP net margins near 50% as revenue outgrows expenses. The primary risk is customer concentration, since a handful of hyperscalers still drive most revenue and any AI capex pause hits a high-beta name hard.
- Upside: If the optical business scales on schedule and Neo clouds reach 20% of revenue, Credo compounds toward the mid-20s IRR the model projects.
- Downside: If the optical ramp slips a quarter or two, the rich multiple compresses and the stock gives back much of its recent run.
Conclusion
The next hard data point is Credo’s fiscal Q1 2027 report, due September 2, 2026, with revenue guided to $465 million to $475 million. Good looks like a print above $475 million with gross margins holding in the high 60s and management putting early hard numbers against the $600 million optical goal. Bad looks like a guide-down or a margin slip toward the mid-60s, which would hand the bears their proof and leave a stock trading above its own analysts’ targets badly exposed. Watch that number. It tells you whether the insiders were early or whether the Street was right to chase.
See what stocks billionaire investors are buying so you can follow the smart money with TIKR.
Should You Invest in Credo?
The only way to really know is to look at the numbers yourself. TIKR gives you free access to the same institutional-quality financial data that professional analysts use to answer exactly that question.
Pull up Credo, and you’ll see years of historical financials, what Wall Street analysts expect for revenue and earnings in the quarters ahead, how valuation multiples have moved over time, and whether price targets are trending up or down.
You can build a free watchlist to track Credo alongside every other stock on your radar. No credit card required. Just the data you need to decide for yourself.
Looking for New Opportunities?
- See what stocks billionaire investors are buying so you can follow the smart money.
- Analyze stocks in as little as 5 minutes with TIKR’s all-in-one, easy-to-use platform.
- The more rocks you overturn… the more opportunities you’ll uncover. Search 100K+ global stocks, global top investor holdings, and more with TIKR.
Disclaimer:
Please note that the articles on TIKR are not intended to serve as investment or financial advice from TIKR or our content team, nor are they recommendations to buy or sell any stocks. We create our content based on TIKR Terminal’s investment data and analysts’ estimates. Our analysis might not include recent company news or important updates. TIKR has no position in any stocks mentioned. Thank you for reading, and happy investing!
